Median PFS was @ months with B+CP and @ months with Pl + CP ( HR , @ ; @ % CI , @ to @ ) in EGFR mutation-positive tumors and @ and @ months , respectively ( HR , @ ; @ % CI , @ to @ ) , in wild-type tumors .